Provides prognostic grading system for clear cell renal cell carcinoma (RCC) based on nuclear morphology and cellular appearance. Independent predictor of cancer-specific survival that correlates nuclear grade with prognosis.
Awaiting Clinical Input
Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.
The Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within urology.
Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.
Small nuclei, round and uniform
Slightly irregular nuclei with visible nucleoli
Obviously irregular nuclei with prominent nucleoli
Pleomorphic nuclei with extreme features
Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.
Open in Web AppClinical Decision Support (CDS) Notice & Legal Disclaimer
This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.